Electrolyte Abnormalities Associated With the Use of Atezolizumab - A Systematic Review.

Rafae, Abdul; Ali, Sundas; Sana, Muhammad Khawar; Rana, Farhan Khalid; Ibrahim, Ahmed; Ahmed, Zahoor; Jan, Ali; Ehsan, Hamid; Fatima, Tehreem; Kunadi, Arvind

Rafae, Abdul; Ali, Sundas; Sana, Muhammad Khawar; Rana, Farhan Khalid; Ibrahim, Ahmed; Ahmed, Zahoor; Jan, Ali; Ehsan, Hamid; Fatima, Tehreem; Kunadi, Arvind.

Afiliação

Rafae A; Department of Internal Medicine, McLaren Flint Michigan State University, Flint, MI, USA.
Ali S; Department of Internal Medicine, Ascension St. Agnes Hospital, Baltimore, MD, USA.
Sana MK; Department of Internal Medicine, McLaren Flint Michigan State University, Flint, MI, USA.
Rana FK; Department of Internal Medicine, John H Stroger Jr Hospital of Cook County, Chicago, IL, USA.
Ibrahim A; Department of Internal Medicine, Monmouth Medical Center, Long Branch, NJ, USA.
Ahmed Z; Rawalpindi Medical University, Rawalpindi, Pakistan.
Jan A; King Edward Medical University, Lahore, Pakistan.
Ehsan H; Department of Internal Medicine, Rochester General Hospital, Rochester, NY, USA.
Fatima T; Levine Cancer Institute, Charlotte, NC, USA.
Kunadi A; Rawalpindi Medical University, Rawalpindi, Pakistan.

J Community Hosp Intern Med Perspect ; 12(2): 35-44, 2022.

Article em En | MEDLINE | ID: mdl-35712686

Palavras-chave

Atezolizumab; Hypokalemia; Hypomagnesemia; Hyponatremia; Malignancy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google